Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

François Bouzom

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Journal of Pharmaceutical Sciences|August 27, 2023
A New Version of the Tissue Composition-Based Model for Improving the Mechanism-Based Prediction of Volume of Distribution at Steady-State for Neutral DrugsPatrick Poulin, Jean-Marie Nicolas, François Bouzom
Biopharmaceutics & Drug Disposition|January 10, 2012
Physiologically based pharmacokinetic (PBPK) modelling tools: how to fit with our needs?François Bouzom, Kathryn Ball, Nathalie Perdaems, et al.
Journal of Pharmacokinetics and Pharmacodynamics|January 9, 2009
Drug-drug interaction predictions with PBPK models and optimal multiresponse sampling time designs: application to midazolam and a phase I compound. Part 1: comparison of uniresponse and multiresponse designs using PopDesMarylore Chenel, François Bouzom, Leon Aarons, et al.
The AAPS Journal|June 21, 2013
Physiologically based pharmacokinetic modelling of drug penetration across the blood-brain barrier--towards a mechanistic IVIVE-based approachKathryn Ball, François Bouzom, Jean-Michel Scherrmann, et al.
Biopharmaceutics & Drug Disposition|December 16, 2016
Oral drug absorption in pediatrics: the intestinal wall, its developmental changes and current tools for predictionsJean-Marie Nicolas, François Bouzom, Chanteux Hugues, et al.
Molecular Pharmaceutics|January 23, 2014
A physiologically based modeling strategy during preclinical CNS drug developmentKathryn Ball, François Bouzom, Jean-Michel Scherrmann, et al.
Biopharmaceutics & Drug Disposition|July 22, 2014
Comparing translational population-PBPK modelling of brain microdialysis with bottom-up prediction of brain-to-plasma distribution in rat and humanKathryn Ball, François Bouzom, Jean-Michel Scherrmann, et al.
Journal of Pharmaceutical Sciences|August 7, 2012
Development of a physiologically based pharmacokinetic model for the rat central nervous system and determination of an in vitro-in vivo scaling methodology for the blood-brain barrier permeability of two transporter substrates, morphine and oxycodoneKathryn Ball, François Bouzom, Jean-Michel Scherrmann, et al.
Journal of Pharmacokinetics and Pharmacodynamics|November 14, 2015
Model-based approaches for ivabradine development in paediatric population, part I: study preparation assessmentSophie Peigné, François Bouzom, Karl Brendel, et al.
Journal of Pharmacokinetics and Pharmacodynamics|January 9, 2009
Drug-drug interaction predictions with PBPK models and optimal multiresponse sampling time designs: application to midazolam and a phase I compound. Part 2: clinical trial resultsMarylore Chenel, François Bouzom, Fanny Cazade, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Journal of Pharmaceutical Sciences|August 27, 2023
A New Version of the Tissue Composition-Based Model for Improving the Mechanism-Based Prediction of Volume of Distribution at Steady-State for Neutral DrugsPatrick Poulin, Jean-Marie Nicolas, François Bouzom
Biopharmaceutics & Drug Disposition|January 10, 2012
Physiologically based pharmacokinetic (PBPK) modelling tools: how to fit with our needs?François Bouzom, Kathryn Ball, Nathalie Perdaems, et al.
Journal of Pharmacokinetics and Pharmacodynamics|January 9, 2009
Drug-drug interaction predictions with PBPK models and optimal multiresponse sampling time designs: application to midazolam and a phase I compound. Part 1: comparison of uniresponse and multiresponse designs using PopDesMarylore Chenel, François Bouzom, Leon Aarons, et al.
The AAPS Journal|June 21, 2013
Physiologically based pharmacokinetic modelling of drug penetration across the blood-brain barrier--towards a mechanistic IVIVE-based approachKathryn Ball, François Bouzom, Jean-Michel Scherrmann, et al.
Biopharmaceutics & Drug Disposition|December 16, 2016
Oral drug absorption in pediatrics: the intestinal wall, its developmental changes and current tools for predictionsJean-Marie Nicolas, François Bouzom, Chanteux Hugues, et al.
Molecular Pharmaceutics|January 23, 2014
A physiologically based modeling strategy during preclinical CNS drug developmentKathryn Ball, François Bouzom, Jean-Michel Scherrmann, et al.
Biopharmaceutics & Drug Disposition|July 22, 2014
Comparing translational population-PBPK modelling of brain microdialysis with bottom-up prediction of brain-to-plasma distribution in rat and humanKathryn Ball, François Bouzom, Jean-Michel Scherrmann, et al.
Journal of Pharmaceutical Sciences|August 7, 2012
Development of a physiologically based pharmacokinetic model for the rat central nervous system and determination of an in vitro-in vivo scaling methodology for the blood-brain barrier permeability of two transporter substrates, morphine and oxycodoneKathryn Ball, François Bouzom, Jean-Michel Scherrmann, et al.
Journal of Pharmacokinetics and Pharmacodynamics|November 14, 2015
Model-based approaches for ivabradine development in paediatric population, part I: study preparation assessmentSophie Peigné, François Bouzom, Karl Brendel, et al.
Journal of Pharmacokinetics and Pharmacodynamics|January 9, 2009
Drug-drug interaction predictions with PBPK models and optimal multiresponse sampling time designs: application to midazolam and a phase I compound. Part 2: clinical trial resultsMarylore Chenel, François Bouzom, Fanny Cazade, et al.
Pageof 2